|
|
|
|
|
|
|||||||||||||
|
|
|
|
|||||||||||||||
|
|
Other
|
|
|
|
|||||||||||||
|
|
|||||||||||||||||
|
|
Cardiology
|
||||||||||||||||
|
|
|
|
Valvular Heart Disease Diagnosis/Definition
Not all murmurs are associated with valvular disease. To evaluate a Initial Diagnosis and Management
PA and LAT CXR. 12 lead electrocardiogram. Echo/doppler examination useful in estimating severity of lesion(s) and left ventricle function. Echo/doppler not indicated in young asymptomatic individuals with short midsystolic murmurs (outflow murmurs) consistent with diagnosis of functional murmur. Endocarditis prophylaxis for procedures (AHA recommendations) for stenotic and/or regurgitant lesions. Rheumatic fever prophylaxis for well-established cases of rheumatic valvular heart disease. Ongoing Management and Objectives
Follow-up studies (echocardiogram, multiple gated acquisition scan, etc.) on a schedule as determined by the cardiology consultant. Specialty follow-up schedule and management recommendations as determined by cardiology consultant. Most patients who are asymptomatic do not need to be seen regularly by specialist unless certain criteria of progression are met. Indications for Specialty Care Referral
Asymptomatic patients with progressive cardiac enlargement detected on CXR and/or echocardiogram. Significant change in physical finding (auscultatory or otherwise). Criteria for Return to Primary Care
Chronic condition that can be managed by the PCM with intermittent consultation with the cardiologist.
Last Review for this Guideline:
January 2007 For more information about the guidelines, or if you are interested in making changes or new submissions please contact: The Clinical Guidelines Administrator. |
|
|||||||||||||
|
|
|
|
|
|
|||||||||||||
|
|
|||||||||||||||||
Home |
Guideline Brochure |
Disclaimers |
Privacy and Security
Statement |
Contact the Administrator
|
|||||||||||||||||